Obagi Medical announced Next Health as a key partner in the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. Next Health was selected for its pioneering commitment to longevity, personalized wellness, and aesthetic treatments across its growing network of health optimization centers. Through this real-world evaluation collaboration, Next Health will conduct a structured, multi-site assessment of Obagi saypha MagIQ within its practices. The program will leverage Next Health’s expertise in integrating advanced injectables with holistic protocols, patient-centric education, and data-driven outcomes to generate meaningful real-world evidence on the filler’s performance in wellness-focused environments.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Obagi Medical, Alpha Aesthetic Partners collaborate for ALOHA program
- Obagi Medical, Platinum Dermatology Partners collaborate for ALOHA program
- Obagi Medical unveils ALOHA Program to launch saypha MagIQ
- Waldencast Shareholders Back Board Slate and Auditor at January 2026 AGM
- Waldencast assumed with a Buy at Jefferies